ASX 200 index declines, while Goldman Sachs downgrades rare earths
The stock market index dropped to a low point for the week due to weakness in various sectors. Surprisingly, Australia’s trade surplus was higher than anticipated. St. Barbara’s share prices experienced a significant drop as it returned the proceeds from asset sales to its shareholders. According to Goldman Sachs, the rare earth market is expected […]
Teva’s Strategic Assessment: Israeli Pharmaceutical Firm Considers Selling $2 Billion Active Ingredients Unit
Reports suggest that Teva Pharmaceutical Industries Ltd is exploring potential options for its active pharmaceutical ingredients (API) unit, including a possible sale. Teva has enlisted the help of consultants to search for potential buyers for the unit, which could be valued at around $2 billion. The API unit provides over 400 active ingredients for a […]